Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report

Figure 2

Dose distribution in the second treatment course. Tomotherapy treatment planning with high conformity (conformal index, CI = 1.03). Red, green, and blue areas are 100%, 90%, and 50% of the prescribed radiation dose, respectively. The blue dots outline the lung structure and the sky-blue dots indicate the radiation target.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us